0001225208-18-015769.txt : 20181120 0001225208-18-015769.hdr.sgml : 20181120 20181120214946 ACCESSION NUMBER: 0001225208-18-015769 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181116 FILED AS OF DATE: 20181120 DATE AS OF CHANGE: 20181120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bumpus John P CENTRAL INDEX KEY: 0001422311 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51251 FILM NUMBER: 181196883 MAIL ADDRESS: STREET 1: 103 POWELL COURT, SUITE 200 CITY: BRENTWOOD STATE: TN ZIP: 37027 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LEGACY LIFEPOINT HEALTH, INC. CENTRAL INDEX KEY: 0001301611 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] IRS NUMBER: 201538254 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 330 SEVEN SPRINGS WAY CITY: BRENTWOOD STATE: TN ZIP: 37027 BUSINESS PHONE: 615-920-7600 MAIL ADDRESS: STREET 1: 330 SEVEN SPRINGS WAY CITY: BRENTWOOD STATE: TN ZIP: 37027 FORMER COMPANY: FORMER CONFORMED NAME: LIFEPOINT HEALTH, INC. DATE OF NAME CHANGE: 20150511 FORMER COMPANY: FORMER CONFORMED NAME: LIFEPOINT HOSPITALS, INC. DATE OF NAME CHANGE: 20050421 FORMER COMPANY: FORMER CONFORMED NAME: Lakers Holding Corp. DATE OF NAME CHANGE: 20040826 4 1 doc4.xml X0306 4 2018-11-16 1 0001301611 LEGACY LIFEPOINT HEALTH, INC. LPNT 0001422311 Bumpus John P 330 SEVEN SPRINGS WAY BRENTWOOD TN 37027 1 EVP, Chief Admin. Officer Common 2018-11-14 5 G 0 15384.0000 0.0000 D 103449.0000 D Common 2018-11-16 4 D 0 103449.0000 0 D 0.0000 D Common 2018-11-16 4 D 0 851.0000 0.0000 D 0.0000 I By Retirement Plan Common 2018-11-16 4 D 0 1455.0000 0.0000 D 0.0000 I By Spouse Non-Qualified Stock Options (Right to buy) 44.3400 2018-11-16 4 D 0 35000.0000 0.0000 D 2023-02-19 Common 35000.0000 0.0000 D Non-Qualified Stock Options (Right to buy) 39.9700 2018-11-16 4 D 0 35000.0000 0.0000 D 2022-02-21 Common 35000.0000 0.0000 D Non-Qualified Stock Options (Right to buy) 35.8800 2018-11-16 4 D 0 35000.0000 0.0000 D 2021-02-23 Common 35000.0000 0.0000 D Non-Qualified Stock Options (Right to buy) 64.2200 2018-11-16 4 D 0 31587.0000 0.0000 D 2026-02-23 Common 31587.0000 0.0000 D Non-Qualified Stock Options (Right to buy) 71.0000 2018-11-16 4 D 0 25000.0000 0.0000 D 2025-02-24 Common 25000.0000 0.0000 D Non-Qualified Stock Options (Right to buy) 52.9000 2018-11-16 4 D 0 29000.0000 0.0000 D 2024-02-25 Common 29000.0000 0.0000 D Non-Qualified Stock Options (Right to buy) 44.8500 2018-11-16 4 D 0 47706.0000 0.0000 D 2028-02-27 Common 47706.0000 0.0000 D Non-Qualified Stock Options (Right to buy) 62.5000 2018-11-16 4 D 0 11852.0000 0.0000 D 2027-06-06 Common 11852.0000 0.0000 D Non-Qualified Stock Options (Right to buy) 64.5000 2018-11-16 4 D 0 31918.0000 0.0000 D 2018-02-28 2027-02-28 Common 31918.0000 0.0000 D Restricted Stock Units 0.0000 2018-11-16 4 D 0 27471.0000 D Common 27471.0000 0.0000 D Restricted Stock Units 0.0000 2018-11-16 4 D 0 8618.0000 D 2019-12-31 2019-12-31 Common 8618.0000 0.0000 D Pursuant to the terms of the Agreement and Plan of Merger between the Issuer, RegionalCare Hospital Partners Holdings, Inc. d/b/a RCCH HealthCare Partners, and Legend Merger Sub, Inc. (the "Merger Agreement"), each share of Common Stock issued and outstanding immediately prior to the effective time of the merger was canceled and converted into the right to receive $65.00 in cash, without interest. Pursuant to the terms of the Merger Agreement, each outstanding option, whether vested or unvested, became fully vested as of the effective time of the merger, and was canceled and converted into the right to receive an amount in cash, without interest and less any applicable withholding taxes, determined by multiplying the excess, if any, of the merger consideration of $65.00 per share over the applicable exercise price per share of such option by the number of shares of common stock subject to such option, or if there was no such excess was canceled without consideration. Pursuant to the terms of the Merger Agreement, each outstanding performance-based restricted stock unit ("PRSU"), whether vested or unvested, became fully vested as of the effective time of the merger, and was canceled and converted into the right to receive an amount in cash, without interest and less any applicable withholding taxes, equal to the merger consideration of $65.00 per share multiplied by the number of shares of Common Stock subject to such PRSUs as set forth in the applicable award agreement. /s/ Kathy Teague, Attorney-in-Fact 2018-11-20